A phase 1b study of personalized neoantigen vaccine plus pembrolizumab in adults with advanced cancer

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2021
This article has no abstract
Epistemonikos ID: 98339de8105e45fc30bf1186dabe3c33175db703
First added on: Feb 13, 2025